Skip to main content
Erschienen in: Inflammation 4/2023

31.03.2023 | ORIGINAL ARTICLE

Dehydration Accelerates Cytogenesis and Cyst Growth in Pkd1−/− Mice by Regulating Macrophage M2 Polarization

verfasst von: Yang Yang, Jie Zhou, Dongjuan Zhang, Jiayi Lv, Meihan Chen, Chao Wang, Minghui Song, Fagui He, Shuwei Song, Changlin Mei

Erschienen in: Inflammation | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Adult autosomal dominant polycystic kidney disease (ADPKD) has been shown to be related as a “third hit” to the occurrence of acute or chronic kidney injury. Here, we examined whether dehydration, as a common kidney risk factor, could cause cystogenesis in chronic-onset Pkd1−/− mice by regulating macrophage activation. First, we confirmed that dehydration accelerated cytogenesis in Pkd1−/− mice and that macrophages infiltrated the kidney tissues even earlier than macroscopic cyst formation. Then, microarray analysis suggested that glycolysis pathway may be involved in macrophage activation in Pkd1−/− kidneys under conditions of dehydration. Further, we confirmed glycolysis pathway was activated and lactic acid (L-LA) was overproduced in the Pkd1−/− kidney under conditions of dehydration. We have already proved that L-LA strongly stimulated M2 macrophage polarization and overproduction of polyamine in macrophage in vitro, and in the present study, we further discovered that M2 polarization-induced polyamine production shortened the primary cilia length by disrupting the PC1/PC2 complex. Finally, the activation of L-LA–arginase 1–polyamine pathway contributed to cystogenesis and progressive cyst growth in Pkd1−/− mice recurrently exposed to dehydration.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Spithoven, E.M., A. Kramer, E. Meijer, B. Orskov, C. Wanner, J.M. Abad, N. Aresté, R.A. de la Torre, F. Caskey, C. Couchoud, et al. 2014. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry. Nephrology Dialysis Transplantation 29: Suppl 4 iv15–25. https://doi.org/10.1093/ndt/gfu017 Spithoven, E.M., A. Kramer, E. Meijer, B. Orskov, C. Wanner, J.M. Abad, N. Aresté, R.A. de la Torre, F. Caskey, C. Couchoud, et al. 2014. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry. Nephrology Dialysis Transplantation 29: Suppl 4 iv15–25. https://​doi.​org/​10.​1093/​ndt/​gfu017
3.
Zurück zum Zitat Torres, V.E., A.B. Chapman, O. Devuyst, R.T. Gansevoort, J.J. Grantham, E. Higashihara, R.D. Perrone, H.B. Krasa, J. Ouyang, and F.S. Czerwiec. 2012. Tolvaptan in patients with autosomal dominant polycystic kidney disease. New England Journal of Medicine 367 (25): 2407–2418. https://doi.org/10.1056/NEJMoa1205511.CrossRefPubMed Torres, V.E., A.B. Chapman, O. Devuyst, R.T. Gansevoort, J.J. Grantham, E. Higashihara, R.D. Perrone, H.B. Krasa, J. Ouyang, and F.S. Czerwiec. 2012. Tolvaptan in patients with autosomal dominant polycystic kidney disease. New England Journal of Medicine 367 (25): 2407–2418. https://​doi.​org/​10.​1056/​NEJMoa1205511.CrossRefPubMed
5.
Zurück zum Zitat Wang, A., T. Hirose, Y. Ohsaki, C. Takahashi, E. Sato, I. Oba-Yabana, S. Kinugasa, Y. Muroya, S. Ito, and T. Mori. 2019. Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats. Clinical and Experimental Nephrology 23 (4): 455–464. https://doi.org/10.1007/s10157-018-1669-9.CrossRefPubMed Wang, A., T. Hirose, Y. Ohsaki, C. Takahashi, E. Sato, I. Oba-Yabana, S. Kinugasa, Y. Muroya, S. Ito, and T. Mori. 2019. Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats. Clinical and Experimental Nephrology 23 (4): 455–464. https://​doi.​org/​10.​1007/​s10157-018-1669-9.CrossRefPubMed
12.
Zurück zum Zitat Belliere, J., A. Casemayou, L. Ducasse, A. Zakaroff-Girard, F. Martins, J.S. Iacovoni, C. Guilbeau-Frugier, B. Buffin-Meyer, B. Pipy, D. Chauveau, et al. 2015. Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury. Journal of the American Society of Nephrology 26 (6): 1363–1377. https://doi.org/10.1681/asn.2014040320.CrossRefPubMed Belliere, J., A. Casemayou, L. Ducasse, A. Zakaroff-Girard, F. Martins, J.S. Iacovoni, C. Guilbeau-Frugier, B. Buffin-Meyer, B. Pipy, D. Chauveau, et al. 2015. Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury. Journal of the American Society of Nephrology 26 (6): 1363–1377. https://​doi.​org/​10.​1681/​asn.​2014040320.CrossRefPubMed
13.
Zurück zum Zitat García-Trabanino, R., E. Jarquín, C. Wesseling, R.J. Johnson, M. González-Quiroz, I. Weiss, J. Glaser, J. José Vindell, L. Stockfelt, C. Roncal, et al. 2015. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador—a cross-shift study of workers at risk of Mesoamerican nephropathy. Environmental Research 142: 746–755. https://doi.org/10.1016/j.envres.2015.07.007.CrossRefPubMed García-Trabanino, R., E. Jarquín, C. Wesseling, R.J. Johnson, M. González-Quiroz, I. Weiss, J. Glaser, J. José Vindell, L. Stockfelt, C. Roncal, et al. 2015. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador—a cross-shift study of workers at risk of Mesoamerican nephropathy. Environmental Research 142: 746–755. https://​doi.​org/​10.​1016/​j.​envres.​2015.​07.​007.CrossRefPubMed
14.
Zurück zum Zitat Wesseling, C., A. Aragón, M. González, I. Weiss, J. Glaser, C.J. Rivard, C. Roncal-Jiménez, R. Correa-Rotter, and R.J. Johnson. 2016. Heat stress, hydration and uric acid: a cross-sectional study in workers of three occupations in a hotspot of Mesoamerican nephropathy in Nicaragua. BMJ Open 6 (12): e011034. https://doi.org/10.1136/bmjopen-2016-011034 Wesseling, C., A. Aragón, M. González, I. Weiss, J. Glaser, C.J. Rivard, C. Roncal-Jiménez, R. Correa-Rotter, and R.J. Johnson. 2016. Heat stress, hydration and uric acid: a cross-sectional study in workers of three occupations in a hotspot of Mesoamerican nephropathy in Nicaragua. BMJ Open 6 (12): e011034. https://​doi.​org/​10.​1136/​bmjopen-2016-011034
18.
19.
22.
Zurück zum Zitat Zhang, Y., E.A. Daniel, J. Metcalf, Y. Dai, G.A. Reif, and D.P. Wallace. 2022. CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation. Journal of Molecular Cell Biology 14 (7). https://doi.org/10.1093/jmcb/mjac050 Zhang, Y., E.A. Daniel, J. Metcalf, Y. Dai, G.A. Reif, and D.P. Wallace. 2022. CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation. Journal of Molecular Cell Biology 14 (7). https://​doi.​org/​10.​1093/​jmcb/​mjac050
23.
Zurück zum Zitat Yuajit, C., C. Muanprasat, A.R. Gallagher, S.V. Fedeles, S. Kittayaruksakul, S. Homvisasevongsa, S. Somlo, and V. Chatsudthipong. 2014. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease. Biochemical Pharmacology 88 (3): 412–421. https://doi.org/10.1016/j.bcp.2014.01.038.CrossRefPubMed Yuajit, C., C. Muanprasat, A.R. Gallagher, S.V. Fedeles, S. Kittayaruksakul, S. Homvisasevongsa, S. Somlo, and V. Chatsudthipong. 2014. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease. Biochemical Pharmacology 88 (3): 412–421. https://​doi.​org/​10.​1016/​j.​bcp.​2014.​01.​038.CrossRefPubMed
26.
Zurück zum Zitat Happé H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peters DJ. 2009. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Human Molecular Genetics 18 (14): 2532–2542. https://doi.org/10.1093/hmg/ddp190.CrossRefPubMed Happé H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peters DJ. 2009. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Human Molecular Genetics 18 (14): 2532–2542. https://​doi.​org/​10.​1093/​hmg/​ddp190.CrossRefPubMed
Metadaten
Titel
Dehydration Accelerates Cytogenesis and Cyst Growth in Pkd1−/− Mice by Regulating Macrophage M2 Polarization
verfasst von
Yang Yang
Jie Zhou
Dongjuan Zhang
Jiayi Lv
Meihan Chen
Chao Wang
Minghui Song
Fagui He
Shuwei Song
Changlin Mei
Publikationsdatum
31.03.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01806-5

Weitere Artikel der Ausgabe 4/2023

Inflammation 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.